Skip to main content
Michelle Carey, MD, Endocrinology, Silver Spring, MD

MichelleCareyMD

Endocrinology Silver Spring, MD

Diabetes, Lipid Metabolism

Clinical Team Leader; Division of Diabetes, Lipid Disorders, and Obesity; Office of New Drugs at U.S. Food and Drug Administration

Dr. Carey is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Carey's full profile

Already have an account?

Education & Training

  • Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)
    Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Endocrinology, Diabetes, and Metabolism, 2011 - 2013
  • Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital
    Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2008 - 2011
  • Boston University School of Medicine
    Boston University School of MedicineClass of 2008

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2009 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Publications & Presentations

PubMed

Lectures

  • Resveratrol Improves Insulin Resistance without Affecting Muscle Mitochondria in Overweight Humans 
    American Diabetes Association 74th Scientific Sessions - 6/15/2014
  • Opioid Receptor Activation Impairs Hypoglycemic Counterregulation in Humans 
    American Diabetes Association 74th Scientific Sessions - 6/15/2014
  • Vitamin D Repletion Reduces Adipose Tissue Fibrosis and Improves Insulin Sensitivity in Humans 
    American Diabetes Association 74th Scientific Sessions - 6/14/2014
  • Join now to see all

Press Mentions

  • Poll Evaluation Anonymity
    Poll Evaluation AnonymityFebruary 12th, 2016
  • FDA Approves New Class of Medicines To Treat Pediatric Type 2 Diabetes
    FDA Approves New Class of Medicines To Treat Pediatric Type 2 DiabetesJune 22nd, 2023
  • FDA Grants Access to New Class of Paediatric Diabetes Medicine
    FDA Grants Access to New Class of Paediatric Diabetes MedicineJune 22nd, 2023
  • Join now to see all

Professional Memberships

Other Languages

  • Spanish